DanCann Pharma Management

Management criteria checks 2/4

DanCann Pharma's CEO is Jeppe Rasmussen, appointed in Jan 2018, has a tenure of 6.83 years. directly owns 0.23% of the company’s shares, worth €2.63K. The average tenure of the management team and the board of directors is 3.7 years and 3.6 years respectively.

Key information

Jeppe Rasmussen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.8yrs
CEO ownership0.2%
Management average tenure3.7yrs
Board average tenure3.6yrs

Recent management updates

Recent updates


CEO

Jeppe Rasmussen (29 yo)

6.8yrs

Tenure

Mr. Jeppe Krog Rasmussen has been Director of Dancann Pharma A/S since September 20, 2022. He Founded and serves as Chief Executive Officer of Dancann Pharma A/S since 2018 and serves as its Member of Exec...


Leadership Team

NamePositionTenureCompensationOwnership
Jeppe Rasmussen
Founder6.8yrsno data0.23%
€ 2.6k
Peter Sondergaard
Chief Financial Officer1.8yrsno datano data
Jens Markussen
Head of Production3.7yrsno datano data
John Frellsen
Chief Commercial Officer4.8yrsno datano data
Charlotte Jorgensen
Head of Quality Assurance2.3yrsno datano data

3.7yrs

Average Tenure

Experienced Management: DAN's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jeppe Rasmussen
Founder2.2yrsno data0.23%
€ 2.6k
Carsten Trads
Chairman of the Board4.8yrsno data0.027%
€ 307.2
Christian Carlsen
Vice-Chairman3.6yrsno data0.016%
€ 181.6

3.6yrs

Average Tenure

40yo

Average Age

Experienced Board: DAN's board of directors are considered experienced (3.6 years average tenure).